Outside of the Territory. Allergan shall have the sole and exclusive right (but not obligation) to initiate an infringement or other appropriate suit against any Third Party who at any time has infringed, or is suspected of infringing outside of the Territory, any Allergan IP or other Intellectual Property relating to the Product or is using, or suspected of using, without proper authorization any Know-How comprising Allergan IP outside the Territory.
Outside of the Territory. AltaRex intends to research, develop and conduct certain preclinical and clinical activities in order to obtain the necessary regulatory approvals to market and commercialize products incorporating or based directly or indirectly on the Licensed Technology outside of the Territory as AltaRex shall determine in its discretion (hereinafter the “AltaRex Development Program”). AltaRex shall provide prompt written notice to UP of all aspects of the AltaRex Development Program, and shall promptly update UP in writing with respect to all material changes in such AltaRex Development Program that may arise from time to time. UP shall review and approve in writing the AltaRex Development Program, and all material changes thereto from time to time, in an effort to ensure that the Initial Assessment Period and the UP Development Program are not jeopardized or adversely affected by the AltaRex Development Program, such approval not to be unreasonably withheld or delayed by UT. Qualified personnel of UP shall be permitted to participate and collaborate in the Product registration process by AltaRex outside of the Territory, including without limitation the review of filings prior to submission to regulatory authorities outside of the Territory, participation in meetings with regulatory authorities, and interaction with AltaRex personnel on a regular basis regarding the status of regulatory filings. The parties shall closely cooperate on any matters involved in and arising from the development and commercialization process that may materially affect the other party’s efforts to register Products within each party’s respective territory. Each party shall closely consult with the other with regard to its participation in important clinical development meetings. AltaRex shall provide UP with quarterly written progress reports, summarizing in detail AltaRex’s activities relating to the AltaRex Development Program, and will provide such other Information reasonably requested by UP.
Outside of the Territory. If any Regulatory Authority takes or gives notice to G1 or its Affiliates or Third Party Licensees of its intent to take any regulatory action with respect to any activity of G1 or its Affiliates or Third Party Licensees relating to, and that may adversely impact the Development, Manufacture or Commercialization of, any Licensed Compound or Licensed Product, then G1 shall [***]. The costs and expenses of any such regulatory action outside the Territory shall be borne [***]. [***] shall, and shall ensure that its Affiliates and Third Party Licensees, [***]. In addition, each Party shall promptly, but in any event within [***], notify the other Party of any written communication it receives regarding any threatened or pending action or inspection by or from a Third Party, including a Regulatory Authority, that would [***] affect the Exploitation of the Licensed Compounds or Licensed Products outside the Territory.
Outside of the Territory. Subject to the terms of this Agreement, Zai hereby grants to Blueprint a perpetual, irrevocable, royalty-free license, with the right to grant sublicenses through multiple tiers, under the Zai Technology to Exploit the Blueprint Compounds and the Licensed Products in the Field outside of the Territory. Such license under this Section 2.3.2 (Outside of the Territory) will be (a) exclusive under the Zai Collaboration Technology and Xxx’s interest in the Joint Collaboration Technology and (b) non-exclusive under all other Zai Technology.
Outside of the Territory. (a) Subject to the terms of this Agreement, Blueprint hereby grants to CStone a non-exclusive, royalty-free license, with the right to grant sublicenses solely in accordance with Section 2.2 (Sublicensing and Subcontractors), under the Blueprint Technology to perform [***].
Outside of the Territory. Subject to the terms of this Agreement (including CStone’s retained right to perform the Development activities for the Blueprint Compounds and the Collaboration Products in the Field outside of the Territory in accordance with the applicable Global Development Plan), CStone hereby grants to Blueprint a non-exclusive, perpetual, irrevocable, royalty-free license, with the right to grant sublicenses through multiple tiers, under the CStone General Collaboration Technology, CStone Product Collaboration Technology, and CStone’s interests in the Joint Collaboration Technology solely to Exploit Blueprint Compounds, Blueprint Products, and Blueprint Combination Products in the Field outside of the Territory.
